Central and peripheral actions of somatostatin on the growth hormone–IGF-I axis
J. Clin. Invest. Robert D. Murray, et al. 114:349 doi:10.1172/JCI19933 [Go to this article.]

Figure 4
Primary hepatocytes were incubated with vehicle (Control), SRIF, or OCT for 30 minutes before addition of ¹²⁵I-GH. Additional wells were treated in the presence of 5 μg unlabeled GH to quantify residual nonspecific binding. Cells were incubated for 30 minutes in the presence of ¹²⁵I-GH, washed 3 times, and harvested and radioactivity counted. Graph represents total binding with indicated treatment minus nonspecific binding (specific binding). *P < 0.05 compared with control wells.